StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)

Close on Nov 18, 2026Market cap $13.64MP/E –Yield –

Genenta Science S.p.A. revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

No revenue figures for Genenta Science S.p.A.

Genenta Science S.p.A. has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genenta Science S.p.A. figures

See a number that looks wrong?